DAR File No. 39151
This rule was published in the March 15, 2015, issue (Vol. 2015, No. 6) of the Utah State Bulletin.
Commerce, Occupational and Professional Licensing
Naturopathic Physician Formulary
Notice of Proposed Rule
DAR File No.: 39151
Filed: 02/24/2015 09:00:40 AM
Purpose of the rule or reason for the change:
The Naturopathic Formulary Peer Committee determined that the following changes need to be made to the Naturopathic Physician Formulary rule. The Naturopathic Physicians Licensing Board reviewed the recommendations and affirmed that the subsequent modifications need to be made. It should also be noted that a licensed physician (MD) was added to the peer committee by the legislature under S.B. 193 in the 2014 General Session to ensure the physician-prescribing perspective was included in discussions.
Summary of the rule or change:
Proposed amendments to this section add the following noncontrolled substance legend medications to the Naturopathic Physician Formulary: 1) antibacterials, limited to oral, topical and intramuscular administration; 2) miscellaneous antimycobacterials; 3) heparins; 4) selective serotonin- and norepinephrine-reuptake inhibitors; 5) mast-cell stabilizers; 6) expectorants; 7) mydriatics; 8) anti-inflammatory agents; 9) heavy metal antagonists, limited to Dimercaprol, Edetate Calcium Disodium and Succimer; and 10) oxytocics, limited to Oxytocin.
State statutory or constitutional authorization for this rule:
- Section 58-71-101
- Subsection 58-1-202(1)(a)
- Subsection 58-1-106(1)(a)
Anticipated cost or savings to:
the state budget:
The Division will incur minimal costs of approximately $75 to print and distribute the rule once the proposed amendments are made effective. Any costs incurred will be absorbed in the Division's current budget.
The proposed amendments apply only to licensed naturopathic physicians. As a result, the proposed amendments do not apply to local governments.
The proposed amendments apply only to licensed naturopathic physicians. Licensees may work in a small business; however, the proposed amendments would not directly affect the business.
persons other than small businesses, businesses, or local governmental entities:
The proposed amendments apply only to licensed naturopathic physicians. As a result, the proposed amendments do not apply to other persons.
Compliance costs for affected persons:
The proposed amendments should have no increased compliance cost or impact for licensed naturopathic physicians. There may be cost savings to the patients because they may need to see fewer doctors for treatment. Also, there will be a possible increase in revenue to the naturopathic physician, but these savings and revenue increases cannot be estimated due to wide range of circumstances.
Comments by the department head on the fiscal impact the rule may have on businesses:
This filing expands the list of noncontrolled substance legend medications that are within the scope of practice of naturopathic physicians. No compliance costs or other fiscal impact to businesses is anticipated.
Francine A. Giani, Executive Director
The full text of this rule may be inspected, during regular business hours, at the Division of Administrative Rules, or at:Commerce
Occupational and Professional Licensing
HEBER M WELLS BLDG
160 E 300 S
SALT LAKE CITY, UT 84111-2316
Direct questions regarding this rule to:
- Maria Skedros (Lohse) at the above address, by phone at 801-530-6179, by FAX at 801-530-6511, or by Internet E-mail at email@example.com
Interested persons may present their views on this rule by submitting written comments to the address above no later than 5:00 p.m. on:
Interested persons may attend a public hearing regarding this rule:
- 03/30/2015 09:00 AM, Heber Wells Bldg, 160 E 300 S, Conference Room 474 (fourth floor), Salt Lake City, UT
This rule may become effective on:
Mark Steinagel, Director
R156. Commerce, Occupational and Professional Licensing.
R156-71. Naturopathic Physician Practice Act Rule.
R156-71-202. Naturopathic Physician Formulary.
(1) In accordance with Subsections 58-71-102(8) and (12)(a) and Section 58-71-202, the naturopathic physician formulary which consists of noncontrolled substance legend medications deemed appropriate for the primary health care of patients within the scope of practice of naturopathic physicians, the prescription of which is approved by the Division in collaboration with the Naturopathic Formulary Advisory Peer Committee, consists of the following legend drugs, listed by category, with reference numbers identified in the American Hospital Formulary Service (AHFS), published by the American Society of Health System Pharmacists, 2008 edition; including the monographs available on AHFS Drug Information website, which is http://www.ahfsdruginformation.com:
[ forms only]
8:14 Antifungals, oral and topical forms
8:18 Antivirals limited to oral and topical dosage forms, excluding:
8:18:24 Monoclonal Antibodies
8:18:32 Nucleosides and Nucleotides
8:30.92 Miscellaneous Antiprotozoals excluding those whose primary indication is the treatment of infection in immunosuppressed patients (i.e. Pentamidine and Trimetrexate)
8:36 Urinary anti-infectives
12:12.08.12 Selective Beta 2 Adrenergic Agonists
12:12.12 Alpha and Beta Adrenergic Agonists
12:16 Sympatholytic (Adrenergic Blocking) Agents, limited to ergot derivatives
12:20 Skeletal Muscle Relaxants, excluding scheduled medications
20:24 Hemorrheologic Agents
24:04.08 Cardiotonic Agents - limited to Digoxin
24:06 Antilipemic Agents
24:08 Hypotensive Agents - limited to oral dosage forms
24:20 Alpha Adrenergic Blocking Agents
24:24 Beta Adrenergic Blocking Agents - limited to oral dosage forms
24:28 Calcium Channel Blocking Agents - limited to oral dosage forms
24:32 Renin-Angiotensive-Aldosterone System Inhibitors - limited to oral dosage forms
28:08 Analgesics and Antipyretics, excluding scheduled medications
28:16.04.20 Selective-Serotonin Reuptake Inhibitors
28:16.04.24 Serotonin Modulators
28:16.04.28 Tricyclics and Other Norepinephrine-Reuptake Inhibitors
28:16.04.92 Antidepressants, Miscellaneous
40:00 Electrolytic, Caloric, and Water Balance
44:00 Enzymes, limited to digestive and proteolytic
48:10.24 Leukotriene Modifiers
52:08 Corticosteroids (oral, topical, and
injectable), Anti-Inflammatory Agents [
except Ophthmologic Preparations, ]and DMARDS
56:28 H2 Blockers, Anti-ulcer Agents and Acid Suppressants
68:12 Contraceptives, except implants and injections
68:18 Gonadotropins; limited to Gonadotropin, Chorionic
68:20.02 Alpha-Glucosidase Inhibitors
Agents, including Thyroid of glandular
72:00 Local Anesthetics
80:00 Serums, Toxoids, Vaccines
84:00 Skin and Mucous Membrane Agents, excluding Depigmenting and Pigmenting Agents (reference number 84:50)
84:92 Skin and Mucous Membrane Agents, Miscellaneous, excluding Isotretinoin
92:00 Miscellaneous Therapeutic Agents, limited to Antigout, and Bone-Resorption Inhibitors (limited to Raloxifene), and Botulinum Toxin type A (limited to superficial injections)
(2) In addition, the following items or substances, although not listed in Subsection (1), are approved for primary health care:
(a) Amino Acids;
(d) Silver Nitrate;
(e) DHEA (dihydroepiandrosterone);
(f) Pregnenolone; and
(g) Allergy Testing Agents.
(3) In accordance with Subsections 58-71-102(8) and (12)(a) and Section 58-71-202, the naturopathic physician formulary includes a single controlled substance with the reference number identified in the AHFS, published by the American Society of Health System Pharmacists, 2008 edition:
(4) New categories or classes of drugs will need to be approved as part of the formulary prior to prescribing/administering.
(5) The licensed naturopathic physician has the responsibility to be knowledgeable about the medication being prescribed or administered.
KEY: licensing, naturopaths, naturopathic physician
Date of Enactment or Last Substantive Amendment: [
August 16, 2010]
Notice of Continuation: October 20, 2011
Authorizing, and Implemented or Interpreted Law: 58-71-101; 58-1-106(1)(a); 58-1-202(1)(a)
More information about a Notice of Proposed Rule is available online.
The Portable Document Format (PDF) version of the Bulletin is the official version. The PDF version of this issue is available at https://rules.utah.gov/publicat/bull-pdf/2015/b20150315.pdf. The HTML edition of the Bulletin is a convenience copy. Any discrepancy between the PDF version and HTML version is resolved in favor of the PDF version.
Text to be deleted is struck through and surrounded by brackets ([
example]). Text to be added is underlined (). Older browsers may not depict some or any of these attributes on the screen or when the document is printed.
For questions regarding the content or application of this rule, please contact Maria Skedros (Lohse) at the above address, by phone at 801-530-6179, by FAX at 801-530-6511, or by Internet E-mail at firstname.lastname@example.org. For questions about the rulemaking process, please contact the Division of Administrative Rules.